C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 217/26 (2006.01) A61K 31/47 (2006.01)
Patent
CA 2284163
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
Ces inhibiteurs de protéases du VIH, que l'on peut obtenir par synthèse chimique, sont capables d'inhiber ou de bloquer l'activité biologique de la protéase du VIH, ce qui provoque l'arrêt de la réplication du virus du VIH. Ces composés, ainsi que les compositions contenant comme principes actifs ces composés et facultativement d'autres agents antiviraux, conviennent au traitement de patients ou d'hôtes infectés par le virus du VIH, qui est connu pour provoquer le SIDA.
Albizati Kim F.
Kobayashi Takuo
Reich Siegfried
Varney Michael D.
Zhang Kanyin E.
Agouron Pharmaceuticals Inc.
Japan Tobacco Inc.
Sim & Mcburney
LandOfFree
Hiv protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hiv protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1811154